1. Show article details.

    BRIEF-UK'S CMA says Stryker Corp/Wright Medical Deal Resulted Or May Result In Substantial Lessening Of Competition

    Reuters – 10:35 AM ET 06/30/2020

    UK'S CMA: * DECIDED STRYKER CORP/WRIGHT MEDICAL DEAL RESULTED OR MAY RESULT IN SUBSTANTIAL LESSENING OF COMPETITION. * CONSIDERING WHETHER TO ACCEPT AN UNDERTAKING; PARTIES HAVE UNTIL 7 JULY 2020 TO OFFER AN UNDERTAKING TO CMA Source text for Eikon: Further company coverage:

  2. Show article details.

    UK CMA Mulls Undertaking Acceptance in Stryker Corp. Acquisition of Wright Medical

    DJ Business News – 9:32 AM ET 06/30/2020

    The U.K.' s Competition and Market Authority said Tuesday that it believes that the acquisition by Stryker Corp. (SYK) of Wright Medical Group NV (WMGI) is or may result in substantial lessening of competition in the country. The regulator said that it is considering whether to accept an undertaking in lieu of a reference--which would mean that the parties have until July 7 to offer a pledge or promise that might be accepted by the CMA. Last November, Dutch medical-devices maker Wright Medical...

  3. Show article details.

    BRIEF-Stryker Extends Cash Tender Offer For All Outstanding Shares Of Wright Medical

    Reuters – 7:49 AM ET 06/29/2020

    Stryker Corp (SYK): * STRYKER EXTENDS CASH TENDER OFFER FOR ALL OUTSTANDING SHARES OF WRIGHT MEDICAL. * Stryker Corp (SYK) - EXTENDED OFFERING PERIOD OF CASH TENDER OFFER FOR SHARES OF WRIGHT MEDICAL GROUP N.V. * Stryker Corp (SYK) - TENDER OFFER IS NOW SCHEDULED TO EXPIRE ON AUG 31, 2020 Source text for Eikon: Further company coverage:

  4. Show article details.

    Stryker extends cash tender offer for all outstanding shares of Wright Medical

    GlobeNewswire – 7:30 AM ET 06/29/2020

    Stryker announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V.. The tender offer is being made pursuant to the purchase agreement, dated November 4, 2019, among Stryker, Stryker B.V. and Wright Medical.

  5. Show article details.

    Stryker to host conference call on July 30, 2020

    GlobeNewswire – 9:30 AM ET 06/25/2020

    Stryker announced that it will host a conference call on Thursday, July 30, 2020 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2020 and provide an operational update. To participate in the conference call dial 702-4565 or 689-5532 and be prepared to provide conference ID number 1335868 to the operator.

  6. Show article details.

    Oxford Biomedica hires French pharma veteran after signing vaccine deal

    Reuters – 3:01 AM ET 06/01/2020

    Gene and cell therapy firm Oxford Biomedica plc (OXBDF) said on Monday it had appointed French pharmaceutical industry veteran Roch Doliveux as its non-executive chairman, as it eyes a potentially major role in producing coronavirus vaccine. Doliveux, who currently serves as a non-executive director at Stryker Corp (SYK), will take up his role at Oxford from June 24, the company said.

  7. Show article details.

    Innovative Advancements in Medical Imaging Devices Hold the Potential to Save Lives

    PR Newswire – 9:00 AM ET 05/27/2020

    NEW YORK, May 27, 2020 The medical device industry is seeing strong growth thanks to new technologies and developing medical infrastructure around the world. Some of the fastest growing segments in the medical device market by application include diagnostic devices like patient-monitoring systems, MRI machines, diagnostic imaging equipment, and ultrasonic scanning devices.

  8. Show article details.

    Stryker announces pricing of $2.3 billion senior notes offering

    GlobeNewswire – 5:45 PM ET 05/26/2020

    Stryker announced today that it has priced the following senior notes: $650 million aggregate principal amount of the Company’s 1.150% Notes due 2025, $1 billion aggregate principal amount of the Company’s 1.950% Notes due 2030, and $650 million aggregate principal amount of the Company’s 2.900% Notes due 2050.

  9. Show article details.

    RTI Surgical Holdings, Inc.® Appoints Stuart F. Simpson to Board of Directors

    GlobeNewswire – 4:15 PM ET 05/26/2020

    RTI Surgical Holdings, Inc. (RTIX), a global surgical implant company, today announced the appointment of Stuart F. Simpson as an independent member of its board of directors.

  10. Show article details.

    BRIEF-Stryker Corp Files For Potential Three-Part, Notes Offering; Size Not Disclosed

    Reuters – 10:06 AM ET 05/26/2020

    Stryker Corp (SYK): * STRYKER CORP FILES FOR POTENTIAL THREE-PART, NOTES OFFERING; SIZE NOT DISCLOSED - SEC FILING. * Stryker Corp (SYK) - NOTES WILL BE ISSUED IN MINIMUM DENOMINATIONS OF $2,000 AND INTEGRAL MULTIPLES OF $1,000 ABOVE THAT AMOUNT Source text : Further company coverage:

  11. Show article details.

    UK Regulator Starts Formal Probe into Stryker's Acquisition of Wright Medical Group

    DJ Business News – 5:04 AM ET 05/20/2020

    Competition and Markets Authority said Wednesday that it has started a formal investigation into Stryker Corp.' s acquisition of Wright Medical Group N.V. The regulator, which announced an initial probe into the deal last month, said it is looking to see if the merger would lead to a "substantial lessening of competition" within any U.K. market for goods or services. It has set a deadline for July 15 to decide whether to refer the deal for a Phase 2 investigation.

  12. Show article details.

    BRIEF-UK's competition watchdog to probe Stryker Corporation, Wright Medical Group merger

    Reuters – 2:03 AM ET 05/20/2020

    Stryker Corp (SYK): * UK'S COMPETITION AND MARKETS AUTHORITY SAYS START OF CMA MERGER INVESTIGATION: ANTICIPATED ACQUISITION BY STRYKER CORPORATION OF WRIGHT MEDICAL GROUP N.V. * UK'S COMPETITION AND MARKETS AUTHORITY SAYS COMPETITION AND MARKETS AUTHORITY IS CONSIDERING WHETHER IT IS OR MAY BE CASE THAT THIS TRANSACTION, IF CARRIED INTO EFFECT, WILL RESULT IN CREATION OF A RELEVANT MERGER SITUATION ...

  13. Show article details.

    BRIEF-Stryker Declares A $0.575 Per Share Quarterly Dividend

    Reuters – 9:06 AM ET 05/05/2020

    Stryker Corp (SYK): * STRYKER DECLARES A $0.575 PER SHARE QUARTERLY DIVIDEND Source text for Eikon: Further company coverage:

  14. Show article details.

    Stryker declares a $0.575 per share quarterly dividend

    GlobeNewswire – 8:00 AM ET 05/05/2020

    Stryker announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable on July 31, 2020 to shareholders of record at the close of business on June 30, 2020, representing an increase of approximately 11% versus the prior year and unchanged from the previous quarter.

  15. Show article details.

    Stryker reports first quarter 2020 operating results

    GlobeNewswire – 4:05 PM ET 04/30/2020

    Stryker reported operating results for the first quarter of 2020: The response to the COVID-19 pandemic has included unprecedented measures to slow the spread of the virus taken by local governments and health care authorities globally, including the deferral of elective medical procedures and social contact restrictions, which have had a significant negative impact on Stryker’s operations and ...

  16. Show article details.

    BRIEF-Stryker Corp - Effective As Of May 1, Board Approved Temporary Reduction In Base Salary Of Co's CEO

    Reuters – 4:28 PM ET 04/27/2020

    Stryker Corp (SYK): * Stryker Corp (SYK) - EFFECTIVE AS OF MAY 1, BOARD APPROVED TEMPORARY REDUCTION IN BASE SALARY OF CO'S CEO. * STRYKER - KEVIN LOBO, CO'S CEO, WILL RECEIVE 50% REDUCTION IN BASE SALARY, OTHER NAMED EXECUTIVE OFFICERS WILL RECEIVE BETWEEN 20% TO 30% REDUCTION Source text for Eikon: https://bit.ly/2zvIsXT Further company coverage:

  17. Show article details.

    BRIEF-Stryker Extends Cash Tender Offer For All Outstanding Shares Of Wright Medical

    Reuters – 8:41 AM ET 04/27/2020

    Stryker Corp (SYK): * STRYKER EXTENDS CASH TENDER OFFER FOR ALL OUTSTANDING SHARES OF WRIGHT MEDICAL. * STRYKER - TENDER OFFER IS NOW SCHEDULED TO EXPIRE AT 5:00 P.M., EASTERN TIME, ON JUNE 30 Source text for Eikon: Further company coverage:

  18. Show article details.

    Stryker extends cash tender offer for all outstanding shares of Wright Medical

    GlobeNewswire – 7:45 AM ET 04/27/2020

    Stryker announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V.. The tender offer is being made pursuant to the purchase agreement, dated November 4, 2019, among Stryker, Stryker B.V. and Wright Medical.

  19. Show article details.

    BRIEF-UK's CMA Considering If Stryker Corp/Wright Medical Deal May Lessen Competition

    Reuters – 10:33 AM ET 04/21/2020

    UK's CMA: L MAY BE EXPECTED TO RESULT IN A SUBSTANTIAL LESSENING OF COMPETITION Source text for Eikon: Further company coverage:

  20. Show article details.

    UK CMA Starts Initial Probe Into Stryker Corp.'s $4 Billion Acquisition of Wright Medical

    DJ Business News – 8:39 AM ET 04/21/2020

    Competition and Markets Authority said Tuesday that it has started an initial probe into Stryker Corp.' s acquisition of Wright Medical Group NV (WMGI), and that it is inviting comments from interested parties ahead of a formal investigation. The regulator said that it is looking to see if the deal will lead to a substantial lessening of competition within any U.K. market for goods or services. It has set a May 5 deadline for interested parties to comment.

Page:

Today's and Upcoming Events

  • Jul
    30

    SYK to announce Q2 earnings (Confirmed)

Past Events (last 90 days)

  • Jun
    29

    SYK ex-Dividend for $0.58 on 06/29/2020

    • Announce Date: 05/05/2020
    • Record Date: 06/30/2020
    • Pay Date: 07/31/2020
  • Apr
    30

    SYK announced Q1 earnings.

Data provided by Thomson Reuters © 2020

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.